{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:00:20Z","timestamp":1790906420120,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.pbb.2005.06.013","type":"journal-article","created":{"date-parts":[[2005,7,18]],"date-time":"2005-07-18T13:50:06Z","timestamp":1121694606000},"page":"887-893","source":"Crossref","is-referenced-by-count":64,"title":["Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat"],"prefix":"10.1016","volume":"81","author":[{"given":"Jennifer L.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2005.06.013_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.pbb.2005.06.013_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pbb.2005.06.013_bib3","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1523\/JNEUROSCI.18-14-05301.1998","article-title":"A complex program of striatal gene expression induced by dopaminergic stimulation","volume":"18","author":"Berke","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2005.06.013_bib4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm875","article-title":"Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function","volume":"9","author":"Bezard","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.pbb.2005.06.013_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0306-4522(03)00516-5","article-title":"Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats","volume":"121","author":"Bishop","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2005.06.013_bib6","first-page":"275","article-title":"Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- exposed monkeys","volume":"267","author":"Blanchet","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.06.013_bib7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.40.6.927","article-title":"Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease","volume":"40","author":"Boyce","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2005.06.013_bib8","first-page":"167","article-title":"6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding","volume":"240","author":"Breese","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.06.013_bib9","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1523\/JNEUROSCI.20-05-01849.2000","article-title":"Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D(2) dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats","volume":"20","author":"Cai","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2005.06.013_bib10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1124\/jpet.102.036673","article-title":"Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum","volume":"302","author":"Cai","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.06.013_bib11","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.00285.x","article-title":"L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2005.06.013_bib12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nrn877","article-title":"Animal models of neurological deficits: how relevant is the rat?","volume":"3","author":"Cenci","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pbb.2005.06.013_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbr.2003.10.009","article-title":"Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias","volume":"152","author":"Delfino","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2005.06.013_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0304-3940(92)90606-8","article-title":"Dopamine D1 and D2 receptor interactions in the MPTP-treated marmoset","volume":"142","author":"Elliott","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2005.06.013_bib15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.pbb.2005.06.013_bib16","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1523\/JNEUROSCI.22-12-05042.2002","article-title":"D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1\/2\/MAP kinase","volume":"22","author":"Gerfen","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2005.06.013_bib17","first-page":"409","article-title":"Effect of D1 and D2 agonists and antagonists on dyskinesia produced by L-dopa in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys","volume":"259","author":"Gomez-Mancilla","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.06.013_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1212\/WNL.52.4.771","article-title":"D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys","volume":"52","author":"Grondin","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2005.06.013_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-2999(85)90756-3","article-title":"Some in vitro receptor binding properties of [3H]Eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain","volume":"111","author":"Hall","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.06.013_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-8993(90)91674-6","article-title":"Selective localization of striatal D1 receptors to striatonigral neurons","volume":"528","author":"Harrison","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2005.06.013_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0006-8993(92)91111-Q","article-title":"Changes in D2 but not D1 receptor binding in the striatum following a selective lesion of striatopallidal neurons","volume":"590","author":"Harrison","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2005.06.013_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(83)90381-3","article-title":"SCH 23390 \u2014 the first selective dopamine D-1 antagonist","volume":"91","author":"Hyttel","year":"1983","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2005.06.013_bib23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/nbdi.2000.0372","article-title":"Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia","volume":"8","author":"Johansson","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pbb.2005.06.013_bib24","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1471-4159.1986.tb08506.x","article-title":"A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation","volume":"46","author":"Kilpatrick","year":"1986","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2005.06.013_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/jnnp.37.4.427","article-title":"Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias","volume":"37","author":"Klawans","year":"1974","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pbb.2005.06.013_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nbd.2004.07.005","article-title":"Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia","volume":"17","author":"Konradi","year":"2004","journal-title":"Neurobiol Dis"},{"issue":"Pt 7","key":"10.1016\/j.pbb.2005.06.013_bib27","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/brain\/123.7.1365","article-title":"Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease","volume":"123","author":"Lee","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.pbb.2005.06.013_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2005.06.013_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2005.06.013_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0301-0082(91)90032-V","article-title":"On the interpretation of asymmetries of posture and locomotion produced with dopamine agonists in animals with unilateral depletion of striatal dopamine","volume":"36","author":"Miller","year":"1991","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pbb.2005.06.013_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pbb.2005.06.013_bib32","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/WNL.40.2.340","article-title":"Levodopa-induced dyskinesia: review, observations, and speculations","volume":"40","author":"Nutt","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2005.06.013_bib33","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.pbb.2005.06.013_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pbb.2005.06.013_bib35","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa, 056 Study Group","volume":"342","author":"Rascol","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pbb.2005.06.013_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archneur.58.2.249","article-title":"Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease","volume":"58","author":"Rascol","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pbb.2005.06.013_bib37","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1212\/WNL.39.3.336","article-title":"Lisuride, a dopamine agonist in the treatment of early Parkinson's disease","volume":"39","author":"Rinne","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2005.06.013_bib38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/350614a0","article-title":"Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1","volume":"350","author":"Sunahara","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2005.06.013_bib39","first-page":"495","article-title":"Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines","volume":"268","author":"Tang","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2005.06.013_bib40","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1073\/pnas.88.17.7491","article-title":"Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor","volume":"88","author":"Tiberi","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2005.06.013_bib41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","article-title":"Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol Scand Suppl"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305705002169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305705002169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T18:04:31Z","timestamp":1626199471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305705002169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0091305705002169"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2005.06.013","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}